Monday, 31 August 2026European Markets

AERKOMM INC Stock Impressive Slide 26% So Far On Friday, Underperforms Market

Loading stream...

(vianews) - shares of aerkomm inc (cac 40: akom.pa) dropped by a staggering 26.53% to €2.16 at 11:38 est on friday, after five consecutive sessions in a row of losses. cac 40 is dropping 0.11% to €7,214.36, following the last session's upward trend. this seems, up to now, a somewhat negative trend trading session today.

about aerkomm inc

aerkomm inc., together with its subsidiaries, focuses on providing in-flight entertainment and connectivity solutions in the asian pacific region. the company intends to offer airline passengers with broadband in-flight service options, such as wi-fi, cellular, movies, gaming, live tv, and music through built-in in-flight entertainment systems, such as seat-back displays, as well as on passengers' personal devices. it also focuses on providing content management services and e-commerce solutions; and aerkomm k++ system, a ifec system. the company is based in fremont, california.

earnings per share

as for profitability, aerkomm inc has a trailing twelve months eps of €-1.37.

volume

today's last reported volume for aerkomm inc is 40 which is 1900% above its average volume of 2.

more news about aerkomm inc (akom.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com